Élodie Constant

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Jérôme Avouac, Élodie Drumez, É. Hachulla et al. · The Lancet Rheumatology · 2021 · 291 citations · Full text

Life Sciences, Immunology, Internal Medicine +14

Predictors of response and remission in a large cohort of rheumatoid arthritis patients treated with tocilizumab in clinical practice

Yves‐Marie Pers, C. Fortunet, Élodie Constant et al. · Lara D. Veeken · 2013 · 106 citations

Medicine, Internal Medicine, Pharmacotherapy +17

Efficacy and safety of tocilizumab in elderly patients with rheumatoid arthritis

Yves‐Marie Pers, Roxane Schaub, Élodie Constant et al. · Joint Bone Spine · 2014 · 64 citations

Medicine, Immunology, Pharmacotherapy +12

Response to Tocilizumab in Rheumatoid Arthritis Is Not Influenced by the Body Mass Index of the Patient

Yves‐Marie Pers, Marie Godfrin-Valnet, Joseph Lambert et al. · The Journal of Rheumatology · 2015 · 54 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +14

AB0453 Response to TOCILIZUMAB in Rheumatoid Arthritis is not Influenced by the Body Mass Index of the Patient

Yves‐Marie Pers, Marie Godfrin-Valnet, Joseph Lambert et al. · Annals of the Rheumatic Diseases · 2014 · 17 citations

Life Sciences, Internal Medicine, Pharmacotherapy +17